The phosphatase and tensin homologue (PTEN) tumor suppressor is a phosphatidylinositol D3-phosphatase that counteracts the effects of phosphatidylinositol 3-kinase and negatively regulates cell growth and survival. PTEN is itself regulated by phosphorylation on multiple serine and threonine residues in its C terminus. Previous work has implicated casein kinase 2 (CK2) as the kinase responsible for this phosphorylation. Here we showed that CK2 does not phosphorylate all sites in PTEN and that glycogen synthase kinase 3 (GSK3) also participates in PTEN phosphorylation. Although CK2 mainly phosphorylated PTEN at Ser-370 and Ser-385, GSK3 phosphorylated Ser-362 and Thr-366. More importantly, prior phosphorylation of PTEN at Ser-370 by CK2 strongly increased its phosphorylation at Thr-366 by GSK3, suggesting that the two may synergize. Using RNA interference, we showed that GSK3 phosphorylates PTEN in intact cells. Finally, PTEN phosphorylation was affected by insulin-like growth factor in intact cells. We concluded that multiple kinases, including CK2 and GSK3, participate in PTEN phosphorylation and that GSK3 may provide feedback regulation of PTEN.
Phosphatase and tensin homologue (PTEN)2 (1-3) is a tumor suppressor that is frequently mutated in human cancers (4 -8). The 55-kDa PTEN protein was originally described as a dual-specificity protein phosphatase, but biochemical studies soon showed that PTEN was a poor protein phosphatase but an efficient phosphoinositide D3-phosphatase (9). In cells, PTEN acts as a tumor suppressor by antagonizing phosphoinositide 3-kinase (PI3K), which activates the Akt Ser/Thr kinase, which in turn activates proliferative and antiapoptotic signaling pathways (10 -14).Posttranslationally, PTEN is regulated through phosphorylation of a cluster of serine and threonine residues in its C terminus (15-21).Although not required for the activity of the catalytic domain, phosphorylation of the C-terminal region plays an important role in stabilizing the PTEN protein. In its phosphorylated form, the tail is thought to wrap unto the C2 and catalytic domains of PTEN and thereby block the translocation of PTEN to the cytoplasmic face of the plasma membrane (16,22), thus effectively inhibiting the dephosphorylation of the substrates of PTEN. Tail mutants of PTEN tend to have increased catalytic activity but are rapidly degraded in cells.Using a mutagenesis approach, Torres and Pulido (17) showed that the C-terminal region of PTEN is constitutively phosphorylated in vivo between residues 369 and 386, mostly on Ser-370 and Ser-385. They also found that the Ser/Thr protein kinase casein kinase 2 (CK2) can phosphorylate these residues in vitro as well as, to a lower extent, Ser-380, . Vazquez et al. (16) also found that all phosphorylation of PTEN occurred in the C-terminal region (residues 354 -403) and identified Ser-370 plus at least one other residue (Ser-380, Thr-382, Thr-383, or Ser-385) as the sites in vivo. They also reported that mutation of Ser-380, Thr-382, or Thr-383 to alanine redu...